Scott Gottlieb: Trump’s shadow FDA commissioner during Covid-19?

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

A barrage of drug pricing intel

Rachel and I have been chasing lawmakers and bugging congressional staffers and lobbyists all week to bring you the latest intel on the fate of Democrats’ signature drug pricing legislation. Here’s what we know:

Read the rest…

Source link

Back to top button